Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)

Chronic Kidney Disease Clinical Trial

— EPOCH-RRT  

Official title:

Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01952600
• Other study ID #: 110920130510
• Status: Completed
• Phase: N/A
• First received: June 28, 2013
• Last updated: March 21, 2016
• Start date: June 2013
• Est. completion date: December 2015

Study information

• Verified date: March 2016
• Source: Arbor Research Collaborative for Health
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The EPOCH-RRT study seeks to fill knowledge gaps by gaining more understanding of chronic kidney disease (CKD) patients' priorities; assessing the comparative benefits of hemodialysis (HD) versus peritoneal dialysis (PD), with respect to these priorities; and providing tailored information to assist patients with identifying the best dialysis modality fit for their own unique circumstances and perspectives.

The outcomes most relevant to patients ("patient-centered") extend beyond those traditionally assessed in clinical research, with the relative importance varying across patient groups. A tailored decision aid based on these findings can improve patient decision-making processes regarding choice of dialysis modality.

Description:

Empowering Patients On Choices for Renal Replacement Therapy (EPOCH-RRT)study seeks to identify factors that matter the most to patients with kidney disease and study how they are impacted by different types of dialysis. The inclusion of patients, caregivers, and patient advocacy organizations as research partners will assure that the study addresses questions of greatest relevance to patients facing the need for dialysis.

Aim One of EPOCH-RRT identifies outcomes that are most important to different groups of advanced CKD and dialysis patients through qualitative methods applied for conducting in-depth interviews.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 181
• Est. completion date: December 2015
• Est. primary completion date: December 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Individuals 18 years of age or older.

• Individuals with advanced chronic kidney disease or on dialysis (in-center, hemodialysis, or peritoneal dialysis) for at least three months.

Exclusion Criteria:

• Individuals under 18 years of age.

• Individuals unable to provide informed consent.

• Individuals who do not have chronic kidney disease.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Chronic Kidney Disease
• Kidney Diseases
• Renal Insufficiency, Chronic

Locations

Country	Name	City	State
United States	Arbor Research Collaborative for Health	Ann Arbor	Michigan

Sponsors (6)

Lead Sponsor	Collaborator
Arbor Research Collaborative for Health	American Association of Kidney Patients, Henry Ford Health System, National Kidney Foundation, Patient-Centered Outcomes Research Institute, University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient-Centered Outcomes	Differences in patient-centered outcomes across chronic kidney disease, hemodialysis, and peritoneal dialysis patients.	Baseline	No

External Links

•   Arbor Research Collaborative for Health is committed to improving patient care through research that shapes medical policies and practice.
•   The American Association of Kidney Patients is dedicated to improving the lives of kidney patients and their families by helping them deal with the physical, emotional, and social impact of kidney disease.
•   The National Kidney Foundation is a voluntary nonprofit health organization dedicated to preventing kidney disease.
•   The University of Michigan Division of Nephrology is internationally recognized for its excellence in clinical care, rich educational offerings, and diverse research programs.
•   University of Michigan Center for Managing Chronic Disease aims to build the capacity for effective chronic disease prevention and management.